These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21654349)

  • 1. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
    Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
    Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Miksits M; Kneidinger N; Warszawska J; Holzinger U; Kitzberger R; Thalhammer F
    J Antimicrob Chemother; 2007 Nov; 60(5):1085-90. PubMed ID: 17855725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
    Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
    J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
    Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.
    Lopez ND; Phillips KM
    Pharmacotherapy; 2014 Sep; 34(9):e162-8. PubMed ID: 25074285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.
    Kiser TH; Fish DN; Aquilante CL; Rower JE; Wempe MF; MacLaren R; Teitelbaum I
    Crit Care; 2015 Feb; 19(1):32. PubMed ID: 25645660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
    Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
    Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
    Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
    Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
    Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS; Fish DN; Abraham E; Teitelbaum I
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
    Meyer B; Kornek GV; Nikfardjam M; Karth GD; Heinz G; Locker GJ; Jaeger W; Thalhammer F
    J Antimicrob Chemother; 2005 Jul; 56(1):172-9. PubMed ID: 15905303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    Soler-Palacín P; Frick MA; Martín-Nalda A; Lanaspa M; Pou L; Roselló E; de Heredia CD; Figueras C
    J Antimicrob Chemother; 2012 Mar; 67(3):700-6. PubMed ID: 22190607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
    Pascual A; Csajka C; Buclin T; Bolay S; Bille J; Calandra T; Marchetti O
    Clin Infect Dis; 2012 Aug; 55(3):381-90. PubMed ID: 22610925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Zahalkova J; Duricova J; Kacirova I; Brozmanova H; Urbanek K; Grundmann M; Martinek A
    J Chemother; 2012 Apr; 24(2):107-12. PubMed ID: 22546767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.